Investigation of the efficacy and safety of eltrombopag to correct thrombocytopenia in moderate to severe dengue patients - a phase II randomized controlled clinical trial.

导出 LinkOut

翻译打印收藏纠错

作者： Sajib,Chakraborty ^[1] ; Saruar,Alam ^[1] ; Mohammad,Sayem ^[2] ; Mousumi,Sanyal ^[3] ; Tonmoy,Das ^[1] ; Piyal,Saha ^[2] ; Mohammad,Sayem ^[4] ; Bartholomia Keya,Byapari ^[5] ; Chowdhury Tamanna,Tabassum ^[3] ; Ahmedul,Kabir ^[3] ; Md Robed,Amin ^[3] ; A H M Nurun,Nabi ^[2]

作者单位： Translational Systems Biology Laboratory, Department of Biochemistry and Molecular Biology, University of Dhaka, Dhaka 1000, Bangladesh. ^[1] Laboratory of Population Genetics, Department of Biochemistry and Molecular Biology, University of Dhaka, Dhaka 1000, Bangladesh. ^[2] Department of Medicine, Dhaka Medical College, Dhaka, Bangladesh. ^[3] Department of Medicine, Aichi Medical College, Dhaka, Bangladesh. ^[4] Department of Hematology and Pathology, Square Hospitals Limited, Dhaka, Bangladesh. ^[5]

DOI 10.1016/j.eclinm.2020.100624

PMID 33294822

发布时间 2024-03-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

EClinicalMedicine

2020年29-30卷

100624页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Investigation of the efficacy and safety of eltrombopag to correct thrombocytopenia in moderate to severe dengue patients - a phase II randomized controlled clinical trial.

EClinicalMedicine

相似文献

EClinicalMedicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Investigation of the efficacy and safety of eltrombopag to correct thrombocytopenia in moderate to severe dengue patients - a phase II randomized controlled clinical trial.

EClinicalMedicine

相似文献

EClinicalMedicine

相关期刊

检索历史清除